Form D · Biotechnology
REJUVEL BIO-SCIENCES, INC.
Miami, FL · CIK 0001481427
Offering snapshot reported Jul 30, 2015 · SEC filing
- Reported sold
- $85K Offering amount: $335K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $70K Reported outside-investor minimum
- First sale
- Jul 24, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2015 | Initial | $85,000 | No comparison | 1 | SEC filing |
| Nov 25, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-244814
Source: Form D, filed Jul 30, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Scimeca | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Chase Bank Building, 150 Se 2 Nd Ave Suite 403
Miami, FL, 33131
Miami, FL, 33131